Journal of Neurology

, Volume 237, Issue 4, pp 234–238

Myoglobin is a sensitive marker of increased muscle membrane vulnerability

  • M. F. Driessen-Kletter
  • G. J. Amelink
  • P. R. Bär
  • J. van Gijn
Original Investigations

Summary

Changes in muscle proteins in serum after exercise were studied to evaluate the use of such proteins as indicators of increased muscle membrane vulnerability. Seventy-one women were asked to perform bicycle exercise for 45 min at a moderate load; four proteins (creatine kinase — CK, myoglobin — Mb, aldolase — Ald and pyruvate kinase — PK) were measured in serum up to 24 h after exercise. Twenty-one women were carriers of Duchenne's muscular dystrophy (DMD); these are known to show an elevated serum CK activity at rest, as well as an increased CK response after exercise. Fifty women without a family history of neuromuscular disease were tested to obtain normal values: they showed a small peak (18%) of CK activity 8h after exercise, and an even smaller peak of Mb (9%) 1h after exercise. The mean post-exercise increase for both CK and Mb in the 21 DMD carriers was significantly higher than in controls; the maximum of Mb, on average 70% of baseline levels, was reached 1h after exercise and was higher than that for CK (48%), which was reached 8 h after exercise. It is concluded that myoglobin levels after exercise are a good index of increased vulnerability of the muscle membrane.

Key words

Muscle damage Creatine kinase Myoglobin, exercise Duchenne muscular dystrophy Exercise test 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adornato BT, Kagen LJ, King Engel WK (1978) Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: a new adjunct to carrier detection. Lancet II:499–501Google Scholar
  2. 2.
    Amelink GJ, Bär PR (1986) Exercise-induced muscle protein leakage in the rat. Effects of hormonal manipulation. J Neurol Sci 76:61–68Google Scholar
  3. 3.
    Amelink GJ, Kamp HH, Bär PR (1988) Creatine kinase isoenzyme profiles after exercise in the rat: sex-linked differences in leakage of CK-MM. Pflugers Arch Eur J Physiol 412:417–421Google Scholar
  4. 4.
    Bär PR, Amelink GJ (1986) Serum myoglobin after exercise: a useful parameter for the detection of Duchenne carriers. Muscle Nerve 9 (5S):200Google Scholar
  5. 5.
    Bais R, Edwards JB (1982) Creatine kinase CRC Crit Rev Lab Sci 16:291–336Google Scholar
  6. 6.
    Bakker E, Bonten EJ, DeLange LF, Veenema H, Majoor-Krakauer D, Hofker MH, Van Ommen GJB, Pearson PL (1986) DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet 23:573–580Google Scholar
  7. 7.
    Berg A, Haralambie G (1978) Changes in serum creatine kinase and hexose isomerase activity with exercise duration. Eur J Physiol 39:191–201Google Scholar
  8. 8.
    Borleffs JCC, Derksen RHWM, Bär PR (1987) Serum myoglobin and creatine kinase concentrations in patients with polymyositis or dermatomyositis. Ann Rheum Dis 46:173–175Google Scholar
  9. 9.
    Darras BT, Harper JF, Francke U (1987) Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy. N Engl J Med 316:985–992Google Scholar
  10. 10.
    Driessen-Kletter MF, Bär PR, Scholte HR, Hoogenraad TU (1987) A striking correlation between muscle damage after exercise and mitochondrial dysfunction in patients with chronic external ophthalmoplegia (CPEO). J Inherited Metab Dis 10:252–255Google Scholar
  11. 11.
    Gardner MJ, Altman DG (1986) Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 292:746–750Google Scholar
  12. 12.
    Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, Moxley RT, Huntzinger D, Vaughn A, Conneally PM, Bach P, the CIDD group (1985) Clinical investigation in Duchenne dystrophy. V. Use of creatine kinase and pyruvate kinase in carrier detection. Muscle Nerve 8:60–67Google Scholar
  13. 13.
    Herrmann FH, Spiegler AWJ (1983) Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT). J Neurol Sci 62:141–146Google Scholar
  14. 14.
    Herrmann FH, Spiegler A, Wiedemann G (1982) Muscle provocation test. A sensitive method of discrimination between carriers and noncarriers of Duchenne muscular dystrophy. Hum Genet 61:102–104Google Scholar
  15. 15.
    Hoffman EP, Brown BH, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy gene. Cell 51:919–928Google Scholar
  16. 16.
    Hoffman EP, Knudson CM, Campbell KP, Kunkel LM (1987) Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature 330:754–758Google Scholar
  17. 17.
    Jackson MJ, Round JM, Newham DJ, Edwards RHT (1987) An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy. Muscle Nerve 10:15–21Google Scholar
  18. 18.
    Kagen LJ, Scheidt S, Butt A (1975) Myoglobinaemia following acute myocardial infarction. Am J Med 58:177–182Google Scholar
  19. 19.
    Kagen LJ, Moussavi S, Miller SL, Tsairis P (1980) Serum myoglobin in muscular dystrophy. Muscle Nerve 3:221–226Google Scholar
  20. 20.
    Kiessling WR, Ricker K, Pflughaupt KW, Mertens HG, Haubitz I (1981) Serum myoglobin in primary and secondary skeletal muscle disorders. J Neurol 224:229–233Google Scholar
  21. 21.
    King SW, Statland BE, Savory J (1976) The effect of a short burst of exercise on activity values of enzymes in sera of healthy young men. Clin Chem Acta 72:211–218Google Scholar
  22. 22.
    Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1988) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509–517Google Scholar
  23. 23.
    Konagaya M, Takayanagi T, Konagaya Y, Sobue I (1982) The fluctuation of serum myoglobin levels in Duchenne muscular dystrophy and the carrier. J Neurol Sci 55:259–265Google Scholar
  24. 24.
    McComb JM, McMaster EA, Adgey AAJ (1985) Myoglobin in the very early phase of acute myocardial infarction. Ann Clin Biochem 22:152–155Google Scholar
  25. 25.
    Milne CJ (1988) Rhabdomyolysis, myoglobinuria and exercise. Sports Med 6:93–106Google Scholar
  26. 26.
    Miyoshi K, Saito S, Kawai H, Kondo A, Iwasa M, Hayashi T, Yagita M (1978) Radioimmunoassay for human myoglobin — methods and results in patients with skeletal muscle or myocardial disorders. J Lab Clin Med 92:341–352Google Scholar
  27. 27.
    Moncloa F (1987) Worldwide clinical experience with lovastatin/simvastatin. In: Grundy MS, Beran AG (eds) The role of cholesterol in atherosclerosis. Hanley and Belfus, Philadelphia, pp 55–66Google Scholar
  28. 28.
    Norregaard-Hansen K, Bjerre-Knudsen J, Brodthagen U, Jordal R, Paulev PE (1982) Muscle cell leakage due to long distance training. Eur J Appl Physiol 48:177–188Google Scholar
  29. 29.
    Percy ME, Chang LS, Murphy EG, Oss I, Verellen-Dumoulin C, Thompson MW (1982) Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle Nerve 2:329–339Google Scholar
  30. 30.
    Saranchak HJ, Bernstein SH (1974) A new diagnostic test for acute myocardial infarction. The detection of myoglobinuria by radioimmunodiffusion assay. JAMA 228:1251–1255Google Scholar
  31. 31.
    Smit JWA, Amelink GJ, DeBruin TWA, Bär PR, Erkelens DW (1990) Increased human myoglobin creatine kinase serum levels after standardized exercise during simvastatin treatment. Eur J Clin Invest 20:A31Google Scholar
  32. 32.
    Vaananen HK, Takala TES, Tolonen U, Vuori J, Myllyla VV (1988) Muscle-specific carbonic anhydrase III is a more sensitive marker of muscle damage than creatine kinase in neuro-muscular disorders. Arch Neurol 45:1254–1256Google Scholar
  33. 33.
    Walton JN, Gardner-Medwin D (1974) Progressive muscular dystrophy and the myotonic disorders. In: Walton JN (ed) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh London, pp 491–493Google Scholar
  34. 34.
    Watkins SC, Hoffmann EP, Slayter HS, Kunkel LM (1988) Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333:863–866Google Scholar
  35. 35.
    Zatz M, Shapiro LJ, Campion DS, Kaback MM, Otto PA (1980) Serum pyruvate kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker). J Neurol Sci 46:267–279Google Scholar
  36. 36.
    Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AHM, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333:466–469Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • M. F. Driessen-Kletter
    • 1
  • G. J. Amelink
    • 1
  • P. R. Bär
    • 1
  • J. van Gijn
    • 1
  1. 1.University Department of NeurologyUtrechtThe Netherlands
  2. 2.Research Laboratory Neurology, AZUUtrechtThe Netherlands

Personalised recommendations